1. Home
  2. PRCH vs DCTH Comparison

PRCH vs DCTH Comparison

Compare PRCH & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Porch Group Inc.

PRCH

Porch Group Inc.

HOLD

Current Price

$9.19

Market Cap

962.0M

Sector

Technology

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$10.51

Market Cap

350.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRCH
DCTH
Founded
2012
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
962.0M
350.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRCH
DCTH
Price
$9.19
$10.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$17.56
$22.60
AVG Volume (30 Days)
1.5M
500.6K
Earning Date
02-24-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.27
0.03
Revenue
$442,483,000.00
$79,603,000.00
Revenue This Year
N/A
$131.69
Revenue Next Year
$17.06
$39.22
P/E Ratio
$34.40
$308.04
Revenue Growth
N/A
251.54
52 Week Low
$3.72
$8.12
52 Week High
$19.44
$18.23

Technical Indicators

Market Signals
Indicator
PRCH
DCTH
Relative Strength Index (RSI) 41.18 63.49
Support Level $8.86 $9.69
Resistance Level $9.75 $10.37
Average True Range (ATR) 0.36 0.34
MACD 0.13 0.03
Stochastic Oscillator 34.57 78.21

Price Performance

Historical Comparison
PRCH
DCTH

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: